CompareAnumanavsSully.ai

Anumana is an AI cardiology platform for cardiology and health system programs, developing ECG algorithms that flag cardiac conditions to support earlier clinician detection.

1. Clinical role: It supports cardiac imaging and risk stratification rather than autonomous cardiology, so cardiologist review remains essential for interpretation, treatment, and reporting decisions.
2. Best-fit environment: Cardiology and health system programs may benefit most when ECG-AI fits established diagnostic workflows.
3. Evaluation priorities: Buyers should confirm regulatory clearance scope, imaging modality fit, reporting integration, and clinical validation evidence before rollout.
4. Commercial model: Pricing is sales-led and scoped per buyer rather than publicly posted, making deployment scope and support purchasing considerations.

Anumana is best evaluated through a pilot that tests ECG-AI workflow fit, clearance scope, and cardiologist oversight before adoption.

Sully.ai is an AI medical scribe and clinical assistant for clinics and physician practices, supporting ambient capture, structured note drafting, and documentation workflows.

1. Clinical role: It supports documentation rather than autonomous clinical decision-making, so clinician review of every drafted note remains essential before sign-off.
2. Best-fit environment: Clinics and physician practices may benefit most when specialty requirements and EHR workflows align with the product’s documentation approach.
3. Implementation checks: Buyers should assess specialty fit, EHR integration depth, documentation accuracy, clinician training, and rollout requirements before deployment.
4. Commercial model: Pricing is sales-led and scoped per buyer rather than publicly posted, making implementation scope an important purchasing consideration.

Sully.ai is best evaluated through a focused workflow pilot that tests documentation fit, clinician review, and readiness before scaling across teams.